NIKKEI FT Communicable Diseases Conference

Mr. Takeshi AKAHORI

Ambassador, Director-General for Global Issues Ministry of Foreign Affairs of Japan

Hideaki ANAN, MD, PhD, FJSIM

Chief Executive of Medical Crisis Measures, Kanagawa Prefectural Government/

Deputy Director, Fujisawa City Hospital

Dr. ARAKI Hiroto, MD, PhD, MPH

Ministry of Health, Labour and Welfare/ Department of Infectious Disease Prevention and Control, Division of Infectious Disease Prevention and Control/ Director

Dr. Hideki ARAOKA, MD, PhD.

Director, Department of Infectious Diseases, Toranomon Hospital

Dr. Kazunari ASANUMA, MD, PhD

Director-General Health Policy Bureau

Dr. Manica BALASEGARAM

Executive Director/ GARDP (The Global Antibiotic Research & Development Partnership)

Francesca CEDDIA, MD

Senior VP, Respiratory Vaccine, Global Medical, Moderna Inc.

Mr. Thomas B. CUENI

Director General, IFPMA

Mr. Hirotsugu DAISHIMA

Director of the Corporate Communications Division,

Saraya Co., Ltd.

Mr. Safwan DAMES

Africa Business Development Team, Saraya Co., Ltd.

Dr. Lucica DITIU

Executive Director

Stop TB Partnership

Dr. Yohei DOI, MD, PhD

Professor and Chair, Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine

Ms. Tomoko EGUCHI

Managing Director, Remedy & Company Corporation

Dr. Hiroyoshi ENDO

Professor Emeritus

St. Luke’s International University

Prof Jeff FRENCH

Visiting Professor Brighton University Business School UK

and CEO of Strategic Social Marketing

Yoko FUJIMOTO, M.D., Ph.D.,

Vaccine committee/Vice chair/Pharmaceutical Research and Manufacturers of America

Pfizer Japan Inc.

mRNA & Antiviral Lead, Japan

Dr Tedros Adhanom GHEBREYESUS

Director-General

World Health Organization

Yasuyuki GOMI, Ph.D.,

Division Manager, CMC & Production Technology Research Center,BIKEN Co.,Ltd

Dr Malin GRAPE

Sweden’s Ambassador on Antimicrobial Resistance

M.D.,Ph.D Michinari HAMAGUCHI

Director General, Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response(SCARDA), Japan Agency for Medical Research and Development (AMED)

Dr. Akihisa HARADA, M.D., Ph.D.

President & Representative Director

Pfizer Japan Inc.

Mr. Ryousuke HARADA

Senior Exective Editor

Nikkei Inc.

Dr Richard HATCHETT

CEO CEPI

Eiji HINOSHITA, MD, PhD, MSc

Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare of Japan

Shoji HIRASHIMA, Ph.D.

Daiichi Sankyo Co., Ltd.

Representative Director, Senior Executive Officer, Head of Japan Business Unit

Prof. Kenji HIRAYAMA, MD. Ph.D.

Professor / School of Tropical Medicine and Global Health, Nagasaki University

Mr. Yoshihide HIRUTA

Director of International Cooperation, Business Strategy Development,

Sysmex Corporation

Mr. Takeo HOJO

General Manager, Africa Business Development Section

Global Operation Division, SARAYA CO., LTD.

YUKA HONDA, PhD (Medicine)

Project Associate Professor:

Graduate School of Media and Governance, Keio University

Mr.HORI Hiroyuki

Public Health Bureau, Department of Infectious Disease Prevention and Control, Vaccination Division/Director

Ministry of Health, Labour and Welfare

Dr. Kiyotaka HOSHINAGA M.D.,Ph.D.

Chairman, Bord of Directors

FUJITA ACADEMY Fujita Health University

Mr. Atsushi ICHIKAWA

Director General

Office for Promotion of Regional Revitalization

Mr. Masayuki IMAGAWA, M.B.A., M.Sc., R.Ph.

Chief Executive, Japan Association of Vaccine Industries

Head, Vaccine Business Unit, Takeda Pharmaceutical Co., Ltd.

Dr. Akifumi IMAMURA, M.D.

Director,

Department of Infectious Diseases

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Ichiro INNAMI PhD

Professor, Graduate School of Media &

Governance, Keio University

Hajime INOUE, MD, MPH, DrPH

The World Bank

Advisor; Health, Nutrition, and Population

Ken J. ISHII, M.D., Ph.D.

Professor,

Division of Vaccine Science, Department of Microbiology and Immunology

The Institute of Medical Science, The University of Tokyo

Dr. Satoshi IWATA, MD, PhD

Professor, Department of Microbiology, Tokyo Medical University

Professor, Faculty of Life Sciences, Kumamoto University

President, Japan Antibiotics Research Association

Ichiro KAMOSHITA M.D.,Ph.D.

Special Advisor to the Cabinet

Former Minister of the Environment

Prof. Akira KANEKO, MD, PhD, DTM&H

Osaka Metropolitan University/Karolinska Institutet

Prof. Dr. KANO Mitsunobu, MD/PhD

Vice Executive Director, Dean of School of Pharmaceutical Sciences and Professor

Okayama University

Council Member, Science Council of Japan

Dr. Shigeyuki KANO, MD, PhD, Hon PhD (Mahidol)

Director,

Department of Tropical Medicine and Malaria, Research Institute,

National Center for Global Health and Medicine (NCGM)

Dr. Seiya KATO

Director,

Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/ JATA)

Prof. Yoshihiro KAWAOKA DVM, PhD

National Center for Global Health and Medicine Research Center for Global Viral Diseases, Director

The University of Tokyo Pandemic preparedness, Infection and Advanced research center (UTOPIA), Director

University of Tokyo, Institute of Medical Science, Project Professor

Dr. Naoto KEICHO, MD, PhD

Vice Director,

The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association

Ms. Fumiko KIMOTO

Fundamental Science Research Department / Fumakilla Limited

Research & Development Division

Prof. KITA Kiyoshi

Dean and Professor,

School of Tropical Medicine and Global Health,

Nagasaki University

The University of Tokyo, Professor Emeritus

Junichi KOGA, Ph.D

Strategic Center of Biomedical Advanced VaccineResearch and Development for Preparedness and Response (SCARDA) / Provost / Japan Agency for Medical Research and Development（AMED）

Ms. Yoshiko KOJIMA

Section Manager, Public Relations Section

The Research Foundation for Microbial Diseases of Osaka University

Osamu KOMAGATA, Ph.D.

Chief, Laboratory of Vector Control and Pesticide Science in Department of Medical Entomology, National Institute of Infectious Diseases, Japan

Mr. Michikazu KOSHIBA

Head, Center on Global Health Architecture

MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.

Prof. Osamu KUNII, MD, MPH, PhD,

CEO and Executive Director at the GHIT Fund

KUNIMITSU Ayano, MD, MPH, PhD

Member of the House of Representatives

Dr. Kiyoshi KUROKAWA

Chairperson of the Hideyo Noguchi Africa Prize Committee

Professor Emeritus, University of Tokyo, National Graduate Institute for Policy Studies, and Tokai University

Chairman, Health and Global Policy Institute

Dr. Shunsuke MABUCHI

Head of Resilient and Sustainable Systems for Health and Pandemic Preparedness and Response, Technical Advice and Partnerships Department, Strategic Investment and Impact Division, The Global Fund to Fight AIDS, Tuberculosis and Malaria

Prof. Dr. Izuru MAKIHARA

Professor

Research Center for Advanced Science and Technology, University of Tokyo

Mr Robert MATIRU

Director, Programme Management,Unitaid

Keisuke MATSUBAYASHI, MD, PhD, MSc

Senior Manager

Health and Medical Care Department, Suita city

Ms. Arika MATSUI

PoliPoli inc., Director

Ms. Kyoko MATSUMOTO

RDiscovery, KK

Senior Associate

Mr. Shinji MATSUMOTO

Vaccine Working Team/Chair/European Federation of Pharmaceutical Industries and Association Japan (EFPIA Japan )

Mr. Atsushi MIMURA

Director-General of the International Bureau,

Ministry of Finance

Prof. Noboru MINAKAWA Ph.D.

Institute of Tropical Medicine, Nagasaki University

Professor

Mr. Takeshi MITANI

Chairman Japan CMO Association

Mr. Mitsuru MIYATA

CEO

Miyata Institute of Technologies,K.K.

Dr. Daisuke MIZUSHIMA, MD, PhD

National Center for Global Health and Medicine/

AIDS Clinical Center/Manager

Dr. Yasuyoshi MORI, PhD

General Manager

Global Business Office

Eiken Chemical Co.,Ltd.

Mr. Kotaro NAGASAKI

Governor,Yamanashi Prefecture

Mr. Toshiaki NAGASATO

President and Representative Director

KM Biologics Co.,Ltd

Mr. Hiroji NAKAMURA

Senior Councillor, Cabinet Agency for Infectious Disease Crisis Management, Cabinet Secretariat, Government of Japan

Mr. Susumu NAMIKAWA

Customer Experience Creative Center /Managing Director,

Executive Creative Director

Dentsu Inc.

Prof. Yumiko NARA, PhD

Professor,

Graduate School of Human Life and Health Sciences Program,

The Open University of Japan

Mr. Takeshi NARUSE

KM Biologics Co., Ltd.

Senior Managing Executive Officer, Senior Manager R&D Division

Mr. Takatsugu NIKI

Director, ZENSEDAI

Dr. Itaru NISHIZUKA

The Bureau of Public Health,Tokyo Metropolitan

Government / Senior Director for coodination of Infectious Disease Control

Dr. Hideaki NOJIRI, PhD

Professor,

Graduate School of Agricultural and Life Sciences, The University of Tokyo

Mr. Ryoji NORITAKE

CEO and Board Member,

Health and Global Policy Institute (HGPI)

Prof. Kazumasa OGURO

Professor

Hosei University

Norio OHMAGARI, M.D., M.Sc., Ph.D.

Director

National Center for Global Health and Medicine Hospital

Disease Control and Prevention Center

Dr. Yoshinori OHSUMI

Honorary Professor,

Institute of Innovative Research, Tokyo Institute of Technology

Dr. Kunio OKADA

President Non-Profit Organization Kenkokeiei

Ms. Yuri OKURA

Co-President, G7/G20 Youth Japan

Kazuya OMI, Ph.D.

Executive Officer and CTO,

H.U. Group Holdings, Inc.

Dr. Shigeru OMI, MD, PhD

Japan Anti-Tuberculosis Association, Chairman, Representative,Board of Director

World Health Organization (WHO), Regional Office for Western Pacific

Julio Alonso PADILLA, PhD

Assistant Research Professor – Co-director Chagas disease Initiative, Barcelona Institute for Global Health (ISGlobal), Spain

Mr. Michael PEEL

Science Editor

Financial Times

Dr. Brigitte QUENUM

Regional Advisor for Science Systems and Services for All at the UNAIDS Regional Support Team for Asia and the Pacific

Mr. Neren RAU

Policy department Director

CEPI

Dr. John H. REX, MD

Chief Medical Officer, F2G Ltd.

Operating Partner, Advent Life Sciences

PhD. Tomonori SASAKI

Fumakilla LIMITED / Research & Development division / Fundamental Science research department / Assistant senior manager

Takafumi SATO, PhD

Vice President, Laboratory for drug discovery and disease research, Research division, Shionogi & Co., Ltd.

Mr. Tomohisa SATO

Manager,Infectious Diseases Control Office,

Emergency Management Bureau,City of Sapporo

Ms. Takuko SAWADA

Director and Vice Chairperson of the Board,

Shionogi & Co., Ltd.

Mr. Yoichi SHIMADA

Founder/CEO Connect Afya Ltd.

Mr. Hirokazu SHIMODA

Director, Bio-Industry Division,

Ministry of Economy, Trade and Industry(METI)

Prof. Dr. Takayoshi SHIMOHATA, MD, PhD

Chair, Department of Neurology, Gifu University Graduate School of Medicine

Prof. Nahoko SHINDO, MD, PhD

Senior Advisor,

WHO Health Emergencies Programme (WHE),

World Health Organization

Ms. Yuko SHIOZAKI

Managing Executive Officer,

Media Business,

Nikkei Inc.

Mr. Takahiro SOEJIMA

General Manager,

Sales Promotion Department-III, Sales Promotion Office, Sales Division, Eiken Chemical Co., Ltd.

Kengo SONODA, PhD

Development Department, R&D Division / General Manager

KM Biologics Co., Ltd.

Mr. Joji SUGAWARA

Health and Global Policy Institute (HGPI)

Vice President

Jun SUGIHARA, MD, MPH, DTM&H

Principal Deputy Director

Infectious Disease Prevention and Control Division, Infectious Disease Prevention and Control Department, Public Health Bureau, Ministry of Health, Labour and Welfare

Dr. Tomohiko SUGISHITA

Visiting Professor

Tokyo Women’s Medical University

Director, Yakushima Onoaida Clinic

Manabu SUMI, MD, MPH, PhD

Cabinet Councilor,

Cabinet Agency for Infectious Disease Crises Management (CAICM)

Cabinet Office, Government of Japan

Dr. Yosuke SUNAHARA

Kobe University

Graduate School of Law

Prof. Toshiaki SUNAZUKA, PhD

Omura Satoshi Memorial Institute/

Director, Professor : Kitasato University, and The Kitasato Institute

Dr. Motoi SUZUKI, MD PhD

Director

Center for Surveillance, Immunization,

and Epidemiologic Research

National Institute of Infectious Diseases

Prof. Yasuhiro SUZUKI

President

International University of Health & Welfare

Mr. Masao TAKAHASHI

Head, New Investors, Private Sector Partnerships & Innovation , Gavi the Vaccine Alliance

Dr. Yoshihiro TAKAYAMA, MD

Deputy director

Division of Infectious Diseases

Okinawa Chubu Hospital

Mr. Keizo TAKEMI

Minister of Health, Labour and Welfare

Member, the House of Councillors

Mr. Ikuo TAKIZAWA

Senior Deputy Director General, Human Development Department,

Japan International Cooperation Agency

Dr. Nozomi TAKESHITA, MD, PhD

Director

Office of Pandemic Preparedness and Response, Division of Infectious Disease Prevention and Control, Department of Infectious Disease Prevention and Control, Public Health Bureau, Ministry of Health, Labour and Welfare

Mr. Toru TANZAWA

Chairperson Vaccine Subcommittee BIOPHARMACEUTICAL COMMITTEE

Vice President Vaccine Business Department Japane Business Unit Daiichi Sankyo Co., Ltd.

Dr. Toshibumi TANIGUCHI, MD, PhD

Chiba University Hospital

Department of Infectious Diseases / Associate Professor

Dr. Junko TANUMA, MD, PhD

Chief of the Division of AIDS Medical Information, AIDS Clinical Center,

National Center for Global Health and Medicine

Dr. Kazuhiro TATEDA, MD, PhD

Professor

Department of Microbiology and Infectious Diseases /

Toho University School of Medicine

Yasunori TAWARAGI, PhD

Environmental Management and Global Health Group Sustainability Promotion Department

DAIICHI SANKYO CO.,LTD.

Isao TESHIROGI, Ph.D.

Chief Executive Officer

Shionogi & Co., Ltd.

Dr. Amit N. THAKKER

Executive Chairman

Africa Health Business

Mr. Ryota TODOROKI

President, NTDs Youth Organization

Mr. Susumu TSUBAKI

Representative Director / CEO

Asia Africa Investment and Consulting Pte. Ltd.(AAIC)

Hiroaki UENO, Ph.D.

President of Japan Pharmaceutical Manufacturers Association

Mr. Yasuhiro UESHIMA

Chairperson Board of Directors /JAPAN PLATFORM

Hayato URABE, PhD, MPIA

Associate Vice President, Investment Strategy, Portfolio Development & Innovations

Global Health Innovative Technology Fund (GHIT Fund)

Prof. Yoko URYUHARA, MBA, PhD

Professor,

Faculty of Commerce, Doshisha University Director, Social Marketing Research Centre

Dr. Atsushi USAMI

The University of Tokyo Edge Capital Partners Co., Ltd. (UTEC)

Partner and Board Director

Mr. Hajime WATARI

Strategic Planning & Business Management/Director and SVP

EIKEN Chemical CO.LTD.

Mr. Koichi YAMADA

Fujita Health University

Mr. Yasuhide YAMADA

Former Director-General of Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat, Government of Japan

Executive Officer, SHIMIZU CORPORATION

Mr. Hisahiko YANO

Senior Staff Writer Editional Bureau

Nikkei Inc.

Dr. Yasuhiro YASUTOMI, DVM, PhD

Director, Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN)

Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine

Mr. Hiroshi YOSHIDA

NIPRO Co./Senior Exective Officer